VEGFA and hepatocellular carcinoma: RNAi based VEGF siRNAs, delivered by a range of organic and inorganic nanoparticles (NPs), have proved effective to repress VEGF mRNA translation to demonstrate an anti-angiogenic effect on HCC pathogenesis both in vitro and in vivo (see Table 1).